BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9427782)

  • 1. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy and cancer].
    Bjørge T; Tropé C
    Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens, progestins and cancer of the endometrium].
    Laffargue F; Daures JP
    Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do sex steroids cause breast and genital cancers? Epidemiologic data--the current status (July 1993)].
    Beller FK
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):657-66. PubMed ID: 8270146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy and cancer risk].
    Matsushita H; Wakatsuki A
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():805-9. PubMed ID: 23156354
    [No Abstract]   [Full Text] [Related]  

  • 9. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer surveillance during HRT.
    Palacios S
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncologic aspects of estrogen-replacement therapy].
    Berstein LM
    Vopr Onkol; 1998; 44(4):378-82. PubMed ID: 9807197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hormone use to cancer risk.
    Bernstein L; Ross RK; Henderson BE
    J Natl Cancer Inst Monogr; 1992; (12):137-47. PubMed ID: 1616798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
    Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing menopausal symptoms after gynecological cancer.
    Michaelson-Cohen R; Beller U
    Curr Opin Oncol; 2009 Sep; 21(5):407-11. PubMed ID: 19587594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
    Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.
    Horn LC; Dietel M; Einenkel J
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):4-12. PubMed ID: 15927347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.